24Mar
Weeks 186 and 187 in the war on lung cancer have passed. Here are the highlights...
Weeks 186 and 187 in the war on lung cancer have passed. Here are the highlights...
Week 185 in the war on lung cancer has passed. As mentioned in the update last week, due to some findings suggesting a gene called ALK is important in Dyanne's cancer, she started a drug that inhibits ALK: crizotinib. Here is an update on what has happened since...
Weeks 183 and 184 in the war on lung cancer have passed. There has been an interesting turn of events. Here are the highlights...